DelMar Pharmaceuticals, Inc. Gains 41.5%
Tue 21 Jul 20 at 05:33 PM
DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ) rocketted at $1.4, representing a gain of 41.5%. On Mon 20 Jul 20, DMPI:NASDAQ hit a New 2-Week High of $0.99. The stock appeared on our News Catalysts scanner on Fri 17 Jul 20 at 08:23 AM in the 'ACQUISITION' category. From Mon 06 Jul 20, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Wed 10 Jun 20 at $1.53 with a volume of 5M+.
About DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ)
DelMar Pharmaceuticals Inc is a clinical stage drug development company. It is engaged in research and development of cancer indications.
Top 10 Gainers:
- Midatech Pharma plc (MTP:NASDAQ), 152.94%
- Owens & Minor, Inc. (OMI:NYSE), 81.36%
- Novan, Inc. (NOVN:NASDAQ), 78.26%
- Ocugen, Inc. (OCGN:NASDAQ), 61.25%
- Tellurian Inc. (TELL:NASDAQ), 56.44%
- New Concept Energy, Inc. (GBR:NYSEMKT), 47.01%
- Immuron Limited (IMRN:NASDAQ), 42.27%
- DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ), 41.5%
- New Age Beverages Corporation (NBEV:NASDAQ), 41.38%
- Independence Contract Drilling, Inc. (ICD:NYSE), 34.57%